Brazil ENT Devices Market Report 2022 to 2030

Brazil ENT Devices Market Analysis

$ 3999

Brazil's ENT Devices Market is projected to grow from $580 Mn in 2022 to $980 Mn by 2030, registering a CAGR of 6.8% during the forecast period of 2022-30. The rising prevalence of ENT disorders, such as hearing loss, sinusitis, and tonsillitis, is a major driver of the ENT device market. The market is highly competitive, with a large number of players operating in the space, ranging from small, specialized companies to large multinational corporations. The domestic key players in the Brazil ENT devices market include KOLPLAST, Newmed, and Soniclease.

ID: IN10BRMD009 CATEGORY: Medical Devices GEOGRAPHY: Brazil AUTHOR: Dr. Vishwa Modhia

Buy Now

Brazil ENT Devices Market Analysis Summary

Brazil's ENT Devices Market is projected to grow from $580 Mn in 2022 to $980 Mn by 2030, registering a CAGR of 6.8% during the forecast period of 2022-30.

Brazil is an upper middle-income, developing and the largest country in South America bounded by the Atlantic Ocean. In 2022, there will be roughly 8,000 licensed otolaryngologists in Brazil, a nearly 13 % increase from 2020. This figure has been increasing since 2013 when there were approximately 4.9 thousand doctors in this medical sector. As the Brazilian healthcare system develops and more people have access to healthcare services, there is room for growth in the industry. Brazil’s government spent 10.3 % of its GDP on healthcare in 2020.

Brazil ENT Devices Market

Market Dynamics

Market Growth Drivers Analysis

The prevalence of ENT-related illnesses is rising. The Brazilian Institute of Geography and Statistics (IBGE) estimates that roughly 5.7 % of the Brazilian population suffers from some sort of hearing loss. The Brazilian Ministry of Health offers free cochlear implants to qualified patients through the Brazilian Unified Health System (SUS), however waiting lists can be lengthy, and the number of implants available each year is limited. These aspects could boost Brazil's ENT Devices Market.

Market restrains.

Cochlear implants are also utilised in Brazil, but the rate of adoption is modest in comparison to other nations. Only a small %age of people with deafness use hearing aids, with estimates indicating that less than 10% of those who could benefit from hearing aids actually use them. The cost of hearing aids, which can be prohibitively expensive for many Brazilians, is one of the reasons behind this poor use rate. Overall, considerations such as cost and availability of healthcare services limit the use of ENT devices in Brazil. These factors may deter new entrants into the Brazil ENT Devices Market.

Competitive Landscape

Key Players

Soniclease - Based in São Paulo, Brazil, Soniclease produces a range of ENT medical devices, including ear specula, nasal splints, and microdebriders
Newmed - Based in São Paulo, Brazil, Newmed produces a range of medical devices, including ENT devices such as otoscopes, laryngoscopes, and diagnostic sets
KOLPLAST - Based in Santa Catarina, Brazil, KOLPLAST produces a range of medical devices, including ENT devices such as nasal splints, ear syringes, and surgical instruments
MEDPEJ - Based in São Paulo, Brazil, MEDPEJ produces a range of medical devices, including ENT devices such as endoscopes, surgical instruments, and laryngeal masks
NKL - Based in São Paulo, Brazil, NKL produces a range of medical devices, including ENT devices such as ear specula, forceps, and nasal splints

Recent Notable Updates

September 2022: In Brazil, the new Resolution of Anvisa's Collegiate Board of Directors provides for risk classification, notification, and registration regimes, as well as labeling requirements and usage instructions for medical devices, to update rules that were previously insufficiently applicable to the matter through the now replaced Anvisa's Resolution.

Healthcare Policies and Reimbursement Scenarios

In Brazil, ENT (Ear, Nose, and Throat) devices are regulated by the National Health Surveillance Agency (ANVISA), which is responsible for ensuring the safety, efficacy, and quality of medical devices marketed in Brazil. About reimbursement, the Brazilian Unified Health System (SUS) provides free healthcare services to all Brazilian citizens, including access to medical devices for certain conditions. The SUS covers a wide range of medical devices, including hearing aids and cochlear implants, although the availability of these devices can be limited due to the high demand and limited resources of the healthcare system.

1. Executive Summary
1.1 Device Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Regulatory Landscape for Medical Device
1.6 Health Insurance Coverage in Country
1.7 Type of Medical Device
1.8 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Market Size (With Excel and Methodology)
2.2 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

ENT Device Market Segmentation

The ENT Device Market is segmented as mentioned below:

By Product Type (Revenue, USD Billion):

Diagnostic Devices
Surgical Devices
Hearing Aids
Hearing Implants
Co2 Lasers
Image-Guided Surgery Systems

By Diagnostic Devices (Revenue, USD Billion):

Endocsopes
Hearing Screening Devices

By Surgical Device (Revenue, USD Billion):

Powered Surgical Instruments
Radiofrequency (RF) Handpieces
Handheld Instruments
Balloon Sinus Dilation Devices
ENT Supplies
Ear Tubes
Voice Prosthesis Devices

By End Users (Revenue, USD Billion):

Hospitals and Ambulatory Settings
Home Use
ENT Clinics

Methodology for Database Creation

Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.

Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.

How Do We Get It?

Our database is created and maintained through a combination of secondary and primary research methodologies.

1. Secondary Research

With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:

Analyzing historical proprietary data collected from multiple projects.
Regularly updating our existing data sets with new findings and trends.
Ensuring data consistency and accuracy through rigorous validation processes.

With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:

Searching through academic conferences, published research, citations, and social media platforms
Collecting and compiling diverse data to build a comprehensive and detailed database
Continuously updating our database with new information to ensure its relevance and accuracy

2. Primary Research

To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:

Collaborating with local healthcare providers, hospitals, and clinics to gather real-time data.
Conducting surveys, interviews, and field studies to collect fresh data directly from the source.
Continuously refreshing our database to ensure that the information remains current and reliable.
Validating secondary data through cross-referencing with primary data to ensure accuracy and relevance.

Combining Secondary and Primary Research

By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:

Merging historical data from secondary research with real-time data from primary research.
Conducting thorough data validation and cleansing to remove inconsistencies and errors.
Organizing data into a structured format that is easily accessible and usable for various applications.
Continuously monitoring and updating the database to reflect the latest developments and trends in the healthcare field.

Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.